Stocks and Investing
Stocks and Investing
Wed, April 15, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (BHVN) at Hold with Decreased Target to $46 on, Apr 15th, 2020
Matthew Harrison of Morgan Stanley, Maintained "Biohaven Ltd." (BHVN) at Hold with Decreased Target from $49 to $46 on, Apr 15th, 2020.
Matthew has made no other calls on BHVN in the last 4 months.
There are 2 other peers that have a rating on BHVN. Out of the 2 peers that are also analyzing BHVN, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Esther Rajavelu of "Oppenheimer" Maintained at Hold with Decreased Target to $37 on, Tuesday, March 31st, 2020
This is the rating of the analyst that currently disagrees with Matthew
- Vamil Divan of "Mizuho" Initiated at Strong Buy and Held Target at $62 on, Thursday, February 6th, 2020